Litcius/Paper detail

Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial

Shu Ren, Philip M. Hansbro, Wichat Srikusalanukul, Jay C. Horvat, Tegan Hunter, Alexandra C. Brown, Roseanne Peel, Jack Faulkner, Tiffany‐Jane Evans, Shu Chuen Li, David Newby, Alexis Hure, Walter P. Abhayaratna, Sotirios Tsimikas, Ayelet Gonen, Joseph L. Witztum, John Attia, Shu Ren, Philip M. Hansbro, Roseanne Peel, Wichat Srikusalanukul, Walter P. Abhayaratna, David Newby, Alexis Hure, Catherine D’Este, Andrew Tonkin, Ingrid Hopper, Amanda G. Thrift, Christopher Levi, Jonathan Sturm, David N Dürrheim, Joseph Hung, Tom Briffa, Derek P. Chew, Phil Anderson, Lynelle Moon, Mark McEvoy, John Attia

2022Atherosclerosis16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineAntibodyRandomized controlled trialPlaceboPneumococcal polysaccharide vaccinePneumococcal vaccineImmunologyMyocardial infarctionGastroenterologyPulse wave velocityC-reactive proteinStreptococcus pneumoniaeInflammationPathologyPneumococcal diseaseBlood pressureGeneticsAlternative medicineBiologyBacteriaPneumonia and Respiratory InfectionsAtherosclerosis and Cardiovascular DiseasesViral Infections and Immunology Research
Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial | Litcius